Article
Hypersensitive IFN Responses in Lupus Keratinocytes Reveal Key Mechanistic Determinants in Cutaneous Lupus
11 Feb 2019
Abstract excerpt
Abstract Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which 70% of patients experience disfiguring skin inflammation (grouped under the rubric of cutaneous lupus erythematosus [CLE]). There are limited treatment options for SLE and no Food and Drug Administration–approved therapies for CLE. Studies have revealed that IFNs are important mediators for SLE and CLE, but the mechanisms by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
